Genetic risk factors including apolipoprotein (APOE4) ε4 and triggering receptor expressed on myeloid cells 2 (TREM2) have been found to substantially increase the risk of disease, but do not fully account for AD pathogenesis and progression (Karch & Goate, 2015). The gene discussed is TREM2; the disease is Alzheimer disease.